Powered by

AnaptysBio to Present at J.P. Morgan 37th Annual Healthcare Conference

Jan 02, 2019 - GlobeNewswire
Event Announcements

SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced that Hamza Suria, chief executive officer of AnaptysBio, will present at the J.P. Morgan 37th Annual Healthcare Conference on Tuesday, Jan. 8, 2019 at 2:30 p.m. PT at the Westin St. Francis in San Francisco.

A webcast of the presentation will be available t...